Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0QP7 stock hub

LON/0QP7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QP7is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

276.4M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QP7

In the news

Latest news · LON/0QP7

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.5

P25 12.9P50 16.9P75 23.5

Trailing P/E19.7

P25 15.9P50 22.9P75 35.8

ROE14.3

P25 -54.2P50 2.1P75 13.7

ROIC13.4

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QP7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

CHF

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	1,180
Employees Change	-71.1%
Employees Change Percent	-5.68
Enterprise value	CHF 301.1M
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	CH0025343259
Last refreshed	2026-05-10
Market cap	CHF 276.4M
Price	CHF 49.19
Price currency	CHF
Rev Per Employee	190,615.09x
Sector	Healthcare
Sic	3843
Symbol	lon/0QP7
Website	https://www.coltene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.07%
EV Earnings	21.51x
EV/EBIT	15.19x
EV/EBITDA	12.03x
EV/FCF	35.03x
EV/Sales	1.33x
FCF yield	3.11%
Forward P/E	16.51x
P/B ratio	2.93x
P/E ratio	19.74x
P/S ratio	1.23x
PE Ratio10 Y	22.99x
PE Ratio3 Y	20.53x
PE Ratio5 Y	23.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.75%
EBITDA Margin	11.05%
FCF margin	3.82%
Gross margin	65.46%
Gross Profit	CHF 147.2M
Gross Profit Growth	-1.25%
Gross Profit Growth Q	-2.47%
Gross Profit Growth3 Y	0.46%
Gross Profit Growth5 Y	-1.89%
Net Income	CHF 14M
Net Income Growth	-26.99%
Net Income Growth Q	6.26%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	6.58%
Net Income Growth5 Y	-8.96%
Pretax Margin	7.68%
Profit Margin	6.23%
Profit Per Employee	CHF 11,866
Profitable Years	14
ROA	7.09
Roa5y	9.85
ROCE	19.85
ROE	14.28
Roe5y	20.28
ROIC	13.42
Roic5y	18.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.91%
Cagr1y	-18.66%
Cagr3y	-8.2%
Cagr5y	-14.46%
Div CAGR10	-1.31%
Div CAGR3	-14.07%
Div CAGR5	-6.95%
EPS Growth	-27.01
EPS Growth Q	6.57
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	6.63
EPS Growth5 Y	-8.97
FCF Growth	-61.41%
FCF Growth Q	-4.12%
FCF Growth3 Y	-16.7%
FCF Growth5 Y	-19.13%
OCF Growth	-51.77%
OCF Growth Q	0.79%
OCF Growth10 Y	-8.85%
OCF Growth3 Y	-14.28%
OCF Growth5 Y	-15.88%
Revenue Growth	-4.04x
Revenue Growth Q	-0.54x
Revenue Growth Years	0x
Revenue Growth3 Y	0.17x
Revenue Growth5 Y	-1.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 1.3
Assets	CHF 171.7M
Cash	CHF 19.4M
Current Assets	CHF 119.8M
Current Liabilities	CHF 73.1M
Debt	CHF 44M
Debt EBITDA	CHF 1.77
Debt Equity	CHF 0.47
Debt FCF	CHF 5.12
Equity	CHF 94.2M
Interest Coverage	41.1
Liabilities	CHF 77.5M
Long Term Assets	CHF 51.9M
Long Term Liabilities	CHF 4.4M
Net Cash	CHF -24.6M
Net Cash By Market Cap	CHF -8.9
Net Debt EBITDA	CHF 0.99
Net Debt Equity	CHF 0.26
Net Debt FCF	CHF 2.86
Tangible Book Value	CHF 91.1M
Tangible Book Value Per Share	CHF 15.24
WACC	7.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.64
Inventory Turnover	1.41
Net Working Capital	CHF 70.9M
Quick ratio	0.87
Working Capital	CHF 46.3M
Working Capital Turnover	CHF 4.38

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	-16.55%
Dividend Growth Years	1%
Dividend per share	CHF 1.89
Dividend Years	13
Dividend Yield	3.81%
Ex Div Date	2026-04-23
Last Dividend	CHF 1.89
Payout Frequency	Annual
Payout Ratio	99.9%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	9.46%
1Y total return	-18.65%
200-day SMA	51.32
3Y total return	-22.64%
50-day SMA	50.13
50-day SMA vs 200-day SMA	50under200
5Y total return	-54.19%
All Time High	134
All Time High Change	-63.29%
All Time High Date	2021-05-06
All Time Low	42.4
All Time Low Change	16.02%
All Time Low Date	2025-11-06
ATR	1.01
Beta	0.83
Ch YTD	-8.94
High	49.19
High52	71
High52 Date	2025-06-06
High52ch	-30.71%
Low	49.19
Low52	42.4
Low52 Date	2025-11-06
Low52ch	16.02%
Ma50ch	-1.87%
Price vs 200-day SMA	-4.14%
RSI	48.19
RSI Monthly	43.31
RSI Weekly	45.44
Sharpe ratio	-0.48x
Sortino ratio	-0.46
Total Return	3.82%
Tr YTD	-5.29
Tr1m	4.76%
Tr1w	3.68%
Tr3m	-6.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 19.7M
Operating Income Growth	-1.81
Operating Income Growth Q	-2.79
Operating Income Growth3 Y	4.97
Operating Income Growth5 Y	-8.45
Operating margin	8.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,577,706%
Net Borrowing	6,608,617
Shares Insiders	22.07%
Shares Institutions	11.2%
Shares Qo Q	-1.08%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 8.6M
Average Volume	995.75x
Bv Per Share	15.76
CAPEX	CHF -4.3M
Ch10y	-20.04
Ch1m	0.71
Ch1w	3.68
Ch1y	-21.79
Ch3m	-10.39
Ch3y	-31.29
Ch5y	-62.27
Ch6m	12.19
Change	-0.74%
Change From Open	0.01
Close	49.56
Days Gap	-0.75
Depreciation Amortization	5,206,646.1
Dollar Volume	1,033.1
Earnings Date	2026-07-31
EBIT	CHF 19.7M
EBITDA	CHF 24.8M
EPS	CHF 2.34
F Score	4
FCF	CHF 8.6M
FCF EV Yield	2.85x
Financing CF	-7,665,657
Fiscal Year End	December
Founded	2,005
Graham Number	30.66563
Graham Upside	-37.66
Income Tax	CHF 3.3M
Investing CF	-5,299,714
Is Primary Listing	0
Last Earnings Date	2026-03-06
Last Report Date	2025-12-31
Lynch Fair Value	CHF 12.46
Lynch Upside	-74.67
Ma150	50.46
Ma150ch	-2.51%
Ma20	50.28
Ma20ch	-2.15%
Net CF	-1,120,661
Next Earnings Date	2026-07-31
Open	49.19
P FCF Ratio	32.15
P OCF Ratio	21.41
Payment Date	2026-04-27
Ppne	41,292,527
Price Date	2026-05-08
Price EBITDA	CHF 11.12
Ptbv Ratio	3.03
Relative Volume	0.02x
Revenue	224,925,810x
Tax By Revenue	1.46x
Tax Rate	18.99%
Tr6m	16.69%
Volume	21
Z Score	4.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QP7 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.8%

$1.89 annual per share

Payout ratio

+99.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-6.9%

1 consecutive years of growth

Total shareholder yield

+3.8%

Next ex-dividend date: 2026-04-23

Performance

LON/0QP7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QP7?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.2%

Share of float held by funds and institutions

Insider ownership

+22.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

LON/0QP7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.2

Neutral momentum band

Price vs 200-day MA

-4.1%

50/200-day relationship not available

Beta (5Y)

0.83

Moves roughly with the market

Sharpe ratio

-0.48

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QP7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QP7 stock rating?

lon/0QP7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QP7 analysis?

The full report lives at /stocks/lon/0QP7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QP7?

The latest report frames lon/0QP7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QP7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.